(VIANEWS) – Palomar Holdings (PLMR), LGI Homes (LGIH), Focus Financial Partners (FOCS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Palomar Holdings (PLMR)
49.5% sales growth and 14% return on equity
Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance, commercial flood, real estate error and omission, and real estate investor products. It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.
Earnings Per Share
As for profitability, Palomar Holdings has a trailing twelve months EPS of $2.15.
PE Ratio
Palomar Holdings has a trailing twelve months price to earnings ratio of 27.67. Meaning, the purchaser of the share is investing $27.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14%.
2. LGI Homes (LGIH)
18.5% sales growth and 17.75% return on equity
LGI Homes, Inc. designs, constructs, and sells homes in the United States. It offers entry-level homes, such as detached and attached homes, and move-up homes under the LGI Homes brand name; and luxury series homes under the Terrata Homes brand name. As of December 31, 2020, it owned 113 communities. The company serves in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, South Carolina, Washington, Tennessee, Minnesota, Oklahoma, Alabama, California, Oregon, Nevada, West Virginia, Virginia, and Pennsylvania. LGI Homes, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, LGI Homes has a trailing twelve months EPS of $11.75.
PE Ratio
LGI Homes has a trailing twelve months price to earnings ratio of 11.84. Meaning, the purchaser of the share is investing $11.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.75%.
Sales Growth
LGI Homes’s sales growth is negative 12.3% for the ongoing quarter and 18.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 64.6% and a negative 45.7%, respectively.
3. Focus Financial Partners (FOCS)
18% sales growth and 6.31% return on equity
Focus Financial Partners Inc. provides wealth management services to primarily ultra-high and high net worth individuals, families, and business entities. Its wealth management services include investment advice, financial and tax planning, consulting, tax return preparation, family office services, and other services. The company also offers recordkeeping and administration services; recommends financial products through commissions and distribution fees; and sells investment or insurance products. The company was founded in 2006 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Focus Financial Partners has a trailing twelve months EPS of $0.73.
PE Ratio
Focus Financial Partners has a trailing twelve months price to earnings ratio of 71.51. Meaning, the purchaser of the share is investing $71.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.31%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Focus Financial Partners’s EBITDA is 64.69.
4. Tractor Supply Company (TSCO)
9.5% sales growth and 58.55% return on equity
Tractor Supply Company operates as a rural lifestyle retailer in the United States. The company offers a selection of merchandise, including equine, livestock, pet, and small animal products necessary for their health, care, growth, and containment; hardware, truck, towing, and tool products; seasonal products, such as heating products, lawn and garden items, power equipment, gifts, and toys; work/recreational clothing and footwear; and maintenance products for agricultural and rural use. It provides its products under the 4health, Producer's Pride, American Farmworks, Red Shed, Bit & Bridle, Redstone, Blue Mountain, Retriever, C.E. Schmidt, Ridgecut, Countyline, Royal Wing, Dumor, Strive, Groundwork, Traveller, Huskee, Treeline, JobSmart, TSC Tractor Supply Co, Paws & Claws, and Untamed brands. The company operates its retail stores under the Tractor Supply Company, Orscheln Farm and Home, and Petsense names; and operates websites under the TractorSupply.com and Petsense.com names. It sells its products to recreational farmers, ranchers, and others. The company was founded in 1938 and is based in Brentwood, Tennessee.
Earnings Per Share
As for profitability, Tractor Supply Company has a trailing twelve months EPS of $9.7.
PE Ratio
Tractor Supply Company has a trailing twelve months price to earnings ratio of 22.09. Meaning, the purchaser of the share is investing $22.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.55%.
Volume
Today’s last reported volume for Tractor Supply Company is 1257540 which is 4.84% below its average volume of 1321570.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tractor Supply Company’s EBITDA is 87.5.
5. Canadian Imperial Bank of Commerce (CM)
8.8% sales growth and 10% return on equity
Canadian Imperial Bank of Commerce, a diversified financial institution, provides various financial products and services to personal, business, public sector, and institutional clients in Canada, the United States, and internationally. The company operates through Canadian Personal and Business Banking; Canadian Commercial Banking and Wealth Management; U.S. Commercial Banking and Wealth Management; and Capital Markets. The company offers checking, savings, and business accounts; mortgages; business, car, and other loans; lines of credit, student lines of credit, and agriculture loans; investment and insurance services; and credit cards, as well as mobile, online, and overdraft protection services. It also provides day-to-day banking, borrowing and credit, specialty, investing and private wealth, and international banking services; foreign exchange services; and cash management services. Canadian Imperial Bank of Commerce was founded in 1867 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Canadian Imperial Bank of Commerce has a trailing twelve months EPS of $3.92.
PE Ratio
Canadian Imperial Bank of Commerce has a trailing twelve months price to earnings ratio of 11.12. Meaning, the purchaser of the share is investing $11.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 26, 2023, the estimated forward annual dividend rate is 2.63 and the estimated forward annual dividend yield is 5.99%.
Sales Growth
Canadian Imperial Bank of Commerce’s sales growth is 6.1% for the present quarter and 8.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.8%, now sitting on 21.18B for the twelve trailing months.
Moving Average
Canadian Imperial Bank of Commerce’s worth is higher than its 50-day moving average of $42.48 and higher than its 200-day moving average of $43.37.
6. Globus Medical (GMED)
6.4% sales growth and 10.88% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.95.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 31.25. Meaning, the purchaser of the share is investing $31.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.88%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Globus Medical’s EBITDA is 69.02.
Sales Growth
Globus Medical’s sales growth is 5.8% for the ongoing quarter and 6.4% for the next.
Moving Average
Globus Medical’s value is higher than its 50-day moving average of $56.89 and under its 200-day moving average of $62.80.
Volume
Today’s last reported volume for Globus Medical is 77764 which is 93.1% below its average volume of 1128320.
Previous days news about Globus Medical(GMED)
- According to Zacks on Wednesday, 26 July, "Investors looking for stocks in the Medical – Instruments sector might want to consider either Integer (ITGR Quick QuoteITGR – Free Report) or Globus Medical (GMED Quick QuoteGMED – Free Report) . ", "Currently, both Integer and Globus Medical are holding a Zacks Rank of # 2 (Buy). "
